Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VKORC1 | Q9BQB6 | 1/20 | 0.86 |
| ▸ | NQO1 | P15559 | 5/20 | 0.44 |
| ▸ | PRNP | P04156 | 1/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.37 |
| ▸ | PCSK7 | Q16549 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29455127 | 1.00 | VKORC1 (0.86) | VKORC1NQO1PRNPRXFP1TP53 | |
| SCHEMBL122474 | 1.00 | VKORC1 (0.86) | VKORC1NQO1PRNPRXFP1TP53 | |
| SCHEMBL24003588 | 1.00 | VKORC1 (0.86) | VKORC1NQO1PRNPRXFP1TP53 | |
| SCHEMBL10687567 | 0.94 | VKORC1 (0.78) | VKORC1NQO1PRNPRXFP1TP53 | |
| SCHEMBL10690242 | 0.94 | VKORC1 (0.78) | VKORC1NQO1PRNPRXFP1TP53 | |
| Brodifacoum SCHEMBL435133 | 0.93 | VKORC1 (1.00) | VKORC1NQO1PRNPRXFP1TP53 | |
| Brodifacoum SCHEMBL29455095 | 0.93 | VKORC1 (1.00) | VKORC1NQO1PRNPRXFP1TP53 | |
| SCHEMBL27866042 | 0.93 | VKORC1 (0.81) | VKORC1NQO1PRNPRXFP1TP53 | |
| SCHEMBL10644371 | 0.92 | VKORC1 (0.73) | VKORC1NQO1PRNPRXFP1TP53 | |
| SCHEMBL10688883 | 0.90 | VKORC1 (0.71) | VKORC1NQO1PRNPRXFP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4519376-A1 | PHOTOINITIATOR PACKAGE COMPRISING PHOSPHINE OXIDE PHOTOINITIATORS, COUMARIN-BASED SENSITIZERS AND AMINE ADDITIVES | IGM Group B.V. (NL) | 2025-03-12 | — | — | EP | claimed |
| CN-119137224-A | Photoinitiator package comprising a phosphine oxide photoinitiator, a coumarin-based sensitizer and an amine additive | IGM集团公司 | 2024-12-13 | — | — | CN | claimed |
| WO-2023214013-A1 | PHOTOINITIATOR PACKAGE COMPRISING PHOSPHINE OXIDE PHOTOINITIATORS, COUMARIN-BASED SENSITIZERS AND AMINE ADDITIVES | IGM GROUP B. V. (NL) | 2023-11-09 | — | — | WO | claimed |
| US-12336537-B2 | Fungicidal compositions | SYNGENTA CROP PROTECTION AG (CH) | 2025-06-24 | — | — | US | disclosed |
| EP-4555025-A1 | PHOTOINITIATOR PACKAGE COMPRISING SPECIALISED BISACYLPHOSPHINE OXIDE PHOTOINITIATORS, FURTHER ACYLPHOSPHINE OXIDE PHOTOINITIATORS AND OPTICAL BRIGHTENER SENSITIZERS | IGM Group B.V. (NL) | 2025-05-21 | — | — | EP | disclosed |
| WO-2025073743-A1 | PHOTOINITIATOR PACKAGE COMPRISING SPECIALISED BISACYLPHOSPHINE OXIDE PHOTOINITIATORS, FURTHER ACYLPHOSPHINE OXIDE PHOTOINITIATORS AND OPTICAL BRIGHTENER SENSITIZERS | IGM GROUP B. V. (NL) | 2025-04-10 | — | — | WO | disclosed |
| EP-4519375-A1 | PHOTOINITIATOR PACKAGE COMPRISING SPECIALISED BISACYLPHOSPHINE OXIDE PHOTOINITIATORS AND OPTICAL BRIGHTENER SENSITIZERS | IGM Group B.V. (NL) | 2025-03-12 | — | — | EP | disclosed |
| EP-4519376-A1 | PHOTOINITIATOR PACKAGE COMPRISING PHOSPHINE OXIDE PHOTOINITIATORS, COUMARIN-BASED SENSITIZERS AND AMINE ADDITIVES | IGM Group B.V. (NL) | 2025-03-12 | — | — | EP | disclosed |
| CN-119137224-A | Photoinitiator package comprising a phosphine oxide photoinitiator, a coumarin-based sensitizer and an amine additive | IGM集团公司 | 2024-12-13 | — | — | CN | disclosed |
| EP-4319556-A1 | USE OF ANTI-CLOTTING COMPOUNDS AS RODENTICIDES | Gulba, Dietrich (DE) | 2024-02-14 | — | — | EP | disclosed |
| WO-2023214013-A1 | PHOTOINITIATOR PACKAGE COMPRISING PHOSPHINE OXIDE PHOTOINITIATORS, COUMARIN-BASED SENSITIZERS AND AMINE ADDITIVES | IGM GROUP B. V. (NL) | 2023-11-09 | — | — | WO | disclosed |
| WO-2023214010-A1 | PHOTOINITIATOR PACKAGE COMPRISING SPECIALISED BISACYLPHOSPHINE OXIDE PHOTOINITIATORS AND OPTICAL BRIGHTENER SENSITIZERS | IGM GROUP B. V. (NL) | 2023-11-09 | — | — | WO | disclosed |
| EP-4273200-A1 | PHOTOINITIATOR PACKAGE COMPRISING SPECIALISED BISACYLPHOSPHINE OXIDE PHOTOINITIATORS AND OPTICAL BRIGHTENER SENSITIZERS | IGM Group B.V. (NL) | 2023-11-08 | — | — | EP | disclosed |
| US-20230276805-A1 | FUNGICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2023-09-07 | — | — | US | disclosed |
| WO-2022214485-A1 | USE OF ANTI-CLOTTING COMPOUNDS AS RODENTICIDES | BIOROXX GMBH (DE) | 2022-10-13 | — | — | WO | disclosed |
| CN-111718396-B | Synthetic peptides, pharmaceutical compositions comprising the same, and their use in treating disease associated with embolism | 刘扶东 | 2022-09-16 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230276805-A1 | FUNGICIDAL COMPOSITIONS | CYP51A1, CYP4X1, CYP1B1 | VKORC1 330/4885NQO1 1452/4885PRNP 718/4885 |
| US-12336537-B2 | Fungicidal compositions | CYP51A1, CYP4X1, CYP1B1 | VKORC1 330/4885NQO1 1452/4885PRNP 718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.